Aurinia Pharmaceuticals Inc (AUPH) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aurinia Pharmaceuticals Inc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Aurinia Pharmaceuticals Inc (AUPH) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.3B. It trades at $17.36, up 0.64% today, at 7.4 times earnings. Its overall quality score is 89 out of 100, ranked against the whole US market. 3 analysts' average target of $18.33 implies +5.6% from today's price. Kronos AI's 30-day forecast is −7.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $18.33 |
| Low – high | $16.00 – $21.00 |
| Analysts | 3 |
| Upside to average | +5.6% |
Kronos AI 30-day forecast
| Expected close | $15.92 (−7.7%) |
| Likely range | −9.8% … −6.2% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 97 |
| Solvency | 82 |
| Growth | 87 |
| Overall | 89 |
| P/E | 7.4 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator